Stryker Corporation (SYK)
| Market Cap | 96.33B |
| Revenue (ttm) | 14.72B |
| Net Income (ttm) | 1.41B |
| Shares Out | 376.30M |
| EPS (ttm) | 3.69 |
| PE Ratio | 69.56 |
| Forward PE | 28.01 |
| Dividend | $2.41 |
| Dividend Yield | 0.94% |
| Trading Day | June 15 |
| Last Price | $256.68 |
| Previous Close | $255.69 |
| Change ($) | 0.99 |
| Change (%) | 0.39% |
| Day's Open | 256.44 |
| Day's Range | 255.24 - 257.50 |
| Day's Volume | 625,713 |
| 52-Week Range | 169.82 - 268.04 |
The broad markets tipped lower at the close on Wednesday. The one sector that had a solid move was health care, with an emphasis on drug manufacturers.
PAHC vs. SYK: Which Stock Is the Better Value Option?
As hospitals address the major backlog of pandemic-postponed elective surgeries, medical device makers -- and their stock prices -- could benefit.
Stryker Corp.'s ( SYK , Financial) business was severely impacted by Covid-19 in 2020 as elective surgical procedures were postponed or canceled as the health care industry dealt with the pandemic. Orga...
Stryker (SYK) reported earnings 30 days ago. What's next for the stock?
PAHC vs. SYK: Which Stock Is the Better Value Option?
Stryker to Showcase New, Combined Foot and Ankle Portfolio at 2021 ACFAS Vegas Scientific Conference
MAHWAH, N.J.--(BUSINESS WIRE)--Stryker will showcase its new, combined foot and ankle portfolio at 2021 American College of Foot and Ankle Surgeons Vegas Conference from May 18-21.
You may think dividend investing is all about that yield, but you shouldn't turn a blind eye to growth as well. The post 3 Dividend Stocks for Growth and Total Returns appeared first on InvestorPlace.
We discuss seven hot stocks to buy that could gain traction in the rest of the year The post 7 Hot Stocks To Buy Now For A Summer Of Reopenings appeared first on InvestorPlace. More From InvestorPlace W...
Kalamazoo, MI, May 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of rec...
AHCO vs. SYK: Which Stock Is the Better Value Option?
Rapid innovation is boosting the robotic surgery space, putting the spotlight on Johnson & Johnson (JNJ), Stryker (SYK), Boston Scientific (BSX), Intuitive Surgical (ISRG) and Asensus Surgical (ASXC).
MAHWAH, N.J. & NEW YORK--(BUSINESS WIRE)--Today, Stryker and Minor League Baseball™ (MiLB™) announced a first-of-its-kind multiyear national partnership.
Stryker's (SYK) first-quarter earnings reflect strong performance across Orthopaedics and Neurotechnology and Spine segments.
Kalamazoo, Michigan, April 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the first quarter of 2021:
Stryker (NYSE:SYK) unveils its next round of earnings this Tuesday, April 27. Here is Benzinga's everything-that-matters guide for the earnings announcement.
Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.
Stryker (SYK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Stryker's (SYK) first-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
Stryker (SYK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako and broad product portfolio. However, pricing pressure raises a concern.
Mako is primed to "Stryke" in the second half of the year.
Kalamazoo, Michigan, March 29, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's o...
Kalamazoo, Michigan, March 24, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2021 Annual Meeting of Shareholders is scheduled as follows:
The FDA issued a safety advisory on Stryker Corporation's (NYSE: SYK) Scandinavian Total Ankle Replacement devices, also known as STAR Ankle, citing the risk of a plastic component breaking after surgic...
Kalamazoo, Michigan, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021.
KALAMAZOO, Mich., Feb. 16, 2021 /PRNewswire/ -- C2Dx Inc., a medical device company that invests in and refines the delivery of valuable, niche products to propel their growth, has acquired the T/Pump p...
Kalamazoo, Michigan, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable April 30, 2021 to shareholder...
Stryker's (SYK) fourth-quarter earnings reflect strong segmental performance.
Stryker Corporation (SYK) CEO Kevin Lobo on Q4 2020 Results - Earnings Call Transcript
Stryker (SYK) delivered earnings and revenue surprises of 10.20% and -0.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Stryker (NYSE:SYK) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 12.85% over the past year to $2.81, which beat the es...
Kalamazoo, Michigan, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook:
On Wednesday, January 27, Stryker (NYSE:SYK) will release its latest earnings report. Check out Benzinga's preview to understand the implications.
Stryker's (SYK) fourth-quarter results are likely to reflect strong segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine.
The robotics sector looks poised for a turnaround given the rapid shift to digitization and automation, making it wise to keep an eye on names like iRobot (IRBT), Ambarella (AMBA) and Stryker (SYK)
Stryker's (SYK) acquisition of OrthoSensor will help surgeons with real-time data-driven solutions and improve patient outcomes.
Robotics stocks are poised to grow in 2021, calling for investment in Trimble (TRMB), Rockwell Automation (ROK), ReWalk Robotics (RWLK), Fanuc Corp (FANUY) and Stryker (SYK).
Kalamazoo, Michigan, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company'...
Stryker Corporation is a Dividend Champion with 27 consecutive years of dividend growth. Shares currently yield 1.03%. Stryker Corporation is poised to benefit from an aging and active population.
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
Stryker Corp. (NYSE:SYK) is in the right place with the right portfolio of products and the right strategy to continue its winning streak on Wall Street.
Disappointing jobless data combined with no stimulus and a pandemic continuing to reach grim records caused markets to trade largely mixed today. For investors looking to make the most of this market, t...
Stryker Corporation (SYK) Presents at Evercore ISI Third Annual HealthCONx Conference - Conference Call Transcript
Stryker Corp. said late Wednesday that its board of directors has declared a quarterly dividend of 63 cents a share, payable Jan. 29 to shareholders of record at the close of business on Dec. 31. That's...
About SYK
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other me... [Read more...]
| Industry Medical Devices | Founded 1941 |
| CEO Kevin Lobo | Employees 43,000 |
| Stock Exchange NYSE | Ticker Symbol SYK |
Financial Performance
In 2020, Stryker's revenue was $14.35 billion, a decrease of -3.58% compared to the previous year's $14.88 billion. Earnings were $1.60 billion, a decrease of -23.24%.
Analyst Forecasts
According to 30 analysts, the average rating for Stryker stock is "Buy." The 12-month stock price forecast is 274.09, which is an increase of 6.78% from the latest price.